Her-2/ neu Gene Amplification and Protein Expression in Primary Male Breast Cancer

By Rudlowski Christian  

Breast Cancer Research and Treatment, Vol. 84, Iss. 3, 2004-04 ,pp. : 215-223

Springer Publishing Company

Access to resources Recommend Favorite

Her-2/neu as Predictive Marker for Endocrine Therapy and Chemotherapy in Patients with Metastatic Breast Cancer

By Köstler Wolfgang J.   Zielinski Christoph C.  

Breast Cancer Research and Treatment, Vol. 81, Iss. 1, 2003-01 ,pp. : 73-84

Springer Publishing Company

Access to resources Recommend Favorite

Lapatinib in combination with paclitaxel for the treatment of patients with metastatic breast cancer whose tumors overexpress HER2

By Giordano Sara B   Kaklamani Virginia  

Breast Cancer Management, Vol. 2, Iss. 6, 2013-11 ,pp. : 529-535

Future Medicine

Access to resources Recommend Favorite

A phase I clinical trial of bavituximab and paclitaxel in patients with HER2 negative metastatic breast cancer

By  

Cancer Medicine, Vol. 4, Iss. 7, 2015-07 ,pp. : 1051-1059

John Wiley & Sons Inc

Access to resources Recommend Favorite

Promoter methylation status of the FHIT gene and Fhit expression: Association with HER2/neu status in breast cancer patients

By            

Oncology Reports, Vol. 30, Iss. 5, 2013-01 ,pp. : 2270-2278

Spandidos Publications

Access to resources Recommend Favorite